Bio Solution Co.,Ltd. Logo

Bio Solution Co.,Ltd.

Develops cell therapies, human tissue models, and bio-laboratory products.

086820 | KO

Overview

Corporate Details

ISIN(s):
KR7086820008
LEI:
Country:
South Korea
Address:
서울특별시 노원구 공릉로 232 5층 (공릉동, 서울테크노파크), 서울특별시

Description

Bio Solution Co., Ltd. is a biotechnology company focused on the development, manufacturing, and sale of cell therapy products. The company's core activities involve cell-based biotechnology, producing therapeutics such as autologous chondrocyte treatments for cartilage regeneration. In addition to its therapeutic offerings, Bio Solution develops human tissue models and provides alternative testing solutions. The company also manufactures and distributes a portfolio of bio-laboratory products, including ready-to-use kits, staining solutions, and various reagents for molecular biology research and development applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-01-23 00:00
기업설명회(IR)개최
Korean 6.7 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 823.1 KB
2024-09-30 00:00
대표이사변경
Korean 9.8 KB
2024-09-06 00:00
소송등의판결ㆍ결정
Korean 6.5 KB
2024-08-22 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 12.3 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 965.1 KB
2024-07-09 00:00
본점소재지변경
Korean 5.1 KB
2024-06-28 00:00
기타시장안내 (업종변경 안내)
Korean 4.7 KB
2024-06-13 00:00
투자판단관련주요경영사항(임상시험계획자진취하등) (펠렛형 동종 연골세포치료제카티로이드의 제1/2상 임상시험계획승인 신청I…
Korean 15.2 KB
2024-05-16 00:00
분기보고서 (2024.03)
Korean 774.6 KB
2024-04-15 00:00
투자판단관련주요경영사항(임상시험결과) (카티라이프(바솔자가연골유래연골세포)의 임상 3상 시험 1차 유효성 평가(48주)…
Korean 14.7 KB
2024-03-29 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.6 KB
2024-03-28 00:00
정기주주총회결과
Korean 20.7 KB
2024-03-25 00:00
주요사항보고서(영업정지)
Korean 8.2 KB

Automate Your Workflow. Get a real-time feed of all Bio Solution Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bio Solution Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bio Solution Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.